Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 25    symbols : NVAX    save search
Novavax to Participate in OCTAVE-DUO Study to Evaluate Third Dose of Vaccine in Participants with Impaired Immune Systems
Published: 2021-08-25 (Crawled : 18:00) - biospace.com/
NVAX | $4.09 3.02% 2.93% 2.3M twitter stocktwits trandingview |
Health Technology
 | | O: -1.64% H: 7.27% C: 3.92%
vaccine
Gainers vs Losers
75% 25%

Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M twitter stocktwits trandingview |

AGBA | $2.565 105.2% 51.27% 200M twitter stocktwits trandingview |
Finance
MLEC | $2.44 74.29% 42.62% 78M twitter stocktwits trandingview |
n/a
EDBL | News | $6.28 67.02% 40.13% 16M twitter stocktwits trandingview |

ATGL | $2.91 48.81% 32.8% 180K twitter stocktwits trandingview |

ZAPP | $0.2175 47.16% 32.05% 16M twitter stocktwits trandingview |
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M twitter stocktwits trandingview |
n/a
VIVK | $1.48 38.32% 27.7% 530K twitter stocktwits trandingview |
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M twitter stocktwits trandingview |

SDIG A | $3.635 35.13% 26.0% 1M twitter stocktwits trandingview |

Your saved searches
Save your searches and get alerts when important news are released.